Literature DB >> 22997452

Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

T Seufferlein1, J B Bachet, E Van Cutsem, P Rougier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22997452     DOI: 10.1093/annonc/mds224

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  108 in total

1.  JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer.

Authors:  Chunwan Lu; Asif Talukder; Natasha M Savage; Nagendra Singh; Kebin Liu
Journal:  Oncoimmunology       Date:  2017-02-10       Impact factor: 8.110

Review 2.  Advances in chemotherapy for pancreatic cancer.

Authors:  Bhawna Sirohi; Ashish Singh; Shaheenah Dawood; Shailesh V Shrikhande
Journal:  Indian J Surg Oncol       Date:  2015-01-13

3.  The Long Noncoding RNA HOST2 Promotes Gemcitabine Resistance in Human Pancreatic Cancer Cells.

Authors:  Ning An; Donghui Cheng
Journal:  Pathol Oncol Res       Date:  2018-11-07       Impact factor: 3.201

Review 4.  Albumin-bound paclitaxel: a review of its use for the first-line combination treatment of metastatic pancreatic cancer.

Authors:  Sheridan M Hoy
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

5.  Diagnostic evaluation of simulation CT images for adjuvant radiotherapy in pancreatic adenocarcinoma.

Authors:  Bohyun Kim; Young Chul Kim; O Kyu Noh; Jaesung Heo; Hyun Woo Lee; Ji Hun Kim; Jei Hee Lee; Jai Keun Kim; Oyeon Cho; Young-Taek Oh; Mison Chun
Journal:  Br J Radiol       Date:  2017-07-14       Impact factor: 3.039

6.  Survival of patients with pancreatic cancer treated with varied modalities: A single-centre study.

Authors:  Michael Blaszak; Maher El-Masri; Khalid Hirmiz; John Mathews; Abeer Omar; Tarek Elfiki; Rasna Gupta; Caroline Hamm; Sindu Kanjeekal; Amin Kay; Swati Kulkarni; Akmal Ghafoor
Journal:  Mol Clin Oncol       Date:  2017-03-01

Review 7.  Road map for pain management in pancreatic cancer: A review.

Authors:  Marie José Lahoud; Hampig Raphael Kourie; Joelle Antoun; Lana El Osta; Marwan Ghosn
Journal:  World J Gastrointest Oncol       Date:  2016-08-15

8.  Orthotopic inflammation-related pancreatic carcinogenesis in a wild-type mouse induced by combined application of caerulein and dimethylbenzanthracene.

Authors:  Chen Liang; Zhen Wang; Li Wu; Chen Wang; Bao-Hua Yu; Xiu-Zhong Yao; Xiao-Lin Wang; Ying-Yi Li
Journal:  Tumour Biol       Date:  2015-04-29

9.  Prognostic value of health-related quality of life in patients with metastatic pancreatic adenocarcinoma: a random forest methodology.

Authors:  Momar Diouf; Thomas Filleron; Anne-Laure Pointet; Anne-Claire Dupont-Gossard; David Malka; Pascal Artru; Mélanie Gauthier; Thierry Lecomte; Thomas Aparicio; Anne Thirot-Bidault; Céline Lobry; Francine Fein; Olivier Dubreuil; Bruno Landi; Aziz Zaanan; Julien Taieb; Franck Bonnetain
Journal:  Qual Life Res       Date:  2015-11-28       Impact factor: 4.147

10.  Impact of biliary stent-related events in patients diagnosed with advanced pancreatobiliary tumours receiving palliative chemotherapy.

Authors:  Angela Lamarca; Christina Rigby; Mairéad G McNamara; Richard A Hubner; Juan W Valle
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.